Running title: Loss of p18 INK4c at senescence Key words: INK4/ CDK inhibitors/ senescence/ E2F1/ menin on April 9, Abstract The CDK inhibitors, p18 INK4c and p16 INK4a , both have the credentials of tumor suppressors in human cancers and mouse models. For p16 INK4a , the underlying rationale is its role in senescence but the selective force for inactivation of p18 INK4c in incipient cancer cells is less clear. Here we show that in human fibroblasts undergoing replicative or oncogeneinduced senescence, there is a marked decline in the levels of p18 INK4c protein and RNA, which mirrors the accumulation of p16 INK4a . Downregulation of INK4c is not dependent on p16 INK4a and RAS can promote the loss of INK4c without cell cycle arrest. Down-regulation of p18 INK4c correlates with reduced expression of menin and E2F1 but is unaffected by acute cell cycle arrest or inactivation of the retinoblastoma protein (pRb). Collectively, our data question the idea that p18 INK4c acts as a backup for loss of p16 INK4a and suggest that the apparent activation of p18 INK4c in some settings represents delayed senescence rather than increased expression. We propose that the contrasting behavior of the two very similar INK4 proteins could reflect their respective roles in senescence versus differentiation. on April 9, CAN-11-2552 revised 4 of p18 INK4c correlates with a reduction in the total levels of menin and E2F1, which positively regulate INK4c, but we saw no inverse correlation between INK4c and pRb status in human cancer cells, or between p16 INK4a and p18 INK4c levels as previously suggested. Rather, depletion of p16 INK4a delays the onset of senescence and concomitant down-regulation of p18 INK4c .
Introduction
The INK4 family of cyclin-dependent kinase (CDK) inhibitors, p16 INK4a , p15 INK4b , p18 INK4c and p19 INK4d , are structurally and functionally similar (1) .
They comprise between 3.5 and 5 ankyrin-type repeats and bind directly to CDK4 and CDK6, thereby preventing or destabilizing the interaction of these kinases with regulatory D-type cyclins. Although the INK4 proteins demonstrate equivalent affinity for CDK4 and CDK6 in vitro and when overexpressed (2) , the prevailing impression is that they associate preferentially with CDK6 in physiological settings (3) (4) (5) (6) .
The prototypic member of the family, p16 INK4a , is an accredited tumor suppressor that sustains inactivating germline mutations in familial melanoma and is incapacitated by diverse mechanisms in a variety of sporadic cancers on April 9, 2017. © 2011 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on November 11, 2011 ; DOI: 10.1158/0008-5472.CAN- (1). Its tumor suppressor functions are best explained by its role in senescence, either in response to an activated oncogene or in cells that reach the end of their proliferative lifespan (7) . The INK4b gene, which is tandemly linked to INK4a on human chromosome 9p21, is also implicated in senescence (7) and has credentials as a tumor suppressor in some contexts, but inactivating mutations of p15 INK4b are very rare (1) .
The same applies to p18 INK4c and p19 INK4d but there has recently been renewed interest in the potential role of INK4c in tumor suppression. The most compelling evidence comes from mice carrying null alleles of Ink4c. These animals develop spontaneous pituitary adenomas late in life (8) 
but when
Ink4c deficiency is combined with other gene knockouts, the range and frequency of tumors becomes more extensive. For example, mice lacking both p18 Ink4c and p27 Kip1 develop a tumor spectrum reminiscent of human multiple endocrine neoplasia type 1 (MEN1) (9) . Critically, menin, the product of the MEN1 gene, has been shown to activate p27 KIP1 and p18 INK4c by enhancing the binding of trithorax group (TrxG) complexes to the respective promoters (10, 11) . Crossing of the knockout mice implicates Ink4c as the critical target of menin in this system (12) . Another important example is the combination of Ink4c and p53 deficiency that results in early onset hemangiosarcoma and medullablastoma and nicely models the genetic background of the human disease (13, 14) .
In addition to these mouse models, loss or silencing of human p18 INK4c has been recorded in a number of human malignancies (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Glioblastoma multiforme (GBM) is an intriguing example because homozygous deletions and inactivating mutations of INK4c are observed in a tumor that is frequently associated with defects in the p16 INK4a -CDK4-pRb pathway (20) (21) (22) (23) . As a number of the samples showed concordant loss of both INK4a and INK4c, implying that the selection against these components is not mutually exclusive, some have proposed that p18 INK4c acts as a backup for p16 INK4a (21, 23) .
In considering what drives the inactivation of p18 INK4c in human cancers, we investigated whether it contributes to replicative or oncogeneinduced senescence. Remarkably, the accumulation of p16 INK4a in senescent human fibroblasts is accompanied by the virtual elimination of p18 INK4c . Loss Santa Cruz; MEK1/2 (#9122) was from Cell Signalling; menin (AB2605), HRP conjugated anti-GAPDH (AB9482) and a monoclonal antibody (mAb) against CDK6 (AB77674) were from Abcam; CDK4 (DCS31) and p18 INK4c (DCS118) mAbs were from Novus; the cyclin D1 mAb (DCS6) was from BD Pharmingen; a pan-Ras mAb (OP41) was from Oncogene Research; the mAb against p16 INK4a (JC8) was provided by LRI Cell Services using cells originally obtained from J. Koh and E. Harlow. We also generated two rabbit antisera raised against bacterially expressed p18 INK4c (FST1 and FST4) and have previously described in-house reagents against cyclin D1 (287.3), CDK6
(LBO-1) and p16 INK4a (DPAR12) (28) .
Quantitative reverse transcription and PCR. Total RNA was extracted using the Ultra Pure RNA extraction Kit (Roche) (Roche). Reverse transcription was carried out with 0.5-1 µg of RNA using MultiScribe reverse transcriptase and random hexamer primers (Applied Biosystems). One fiftieth of the cDNA was used as a template for quantitative real-time PCR (qRT-PCR) on ABI 7900HT (Applied Biosystems) using Power SYBR Green Master Mix (Applied Biosystems) or TaqMan Universal PCR Master Mix (Applied Biosystems). Expression was normalized to GAPDH. For detection of the INK4a transcript, annealing and extension was done for 1 min at 66°C, while for other transcripts this step was performed at 60°C. Sequences of the primers can be found in Supplementary Table 1 RNA interference. The validated shRNA against p16 INK4a in the pRetroSuper vector was as described (30) . Three different shRNAs targeting human p18 INK4c were generated in pRetroSuper using the following 19nucleotide sequences: A-5'-CTGGTTTCGCTGTCATTCA-3', B-5'-GGGAACCTGCCCTTGCACT-3 and C-5'-GGGGGACACCGCCTGTGAT-3'.
The C sequence was the most effective.
Chromatin immunoprecipitation. Cells were harvested and processed for chromatin immunoprecipitation as described (31) . After sonication, the chromatin was centrifuged to pellet the debris and pre-cleared at 4°C for 2h with protein A-agarose and protein G-sepharose. The samples were immunoprecipitated with 4µg of relevant antibody or a control IgG at 4°C overnight, followed by a 3h incubation with blocked protein A-or protein G- Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on November 11, 2011; DOI: 10.1158/0008-5472. CAN-11-2552 sepharose. The antibody-chromatin complexes were extensively washed with ice-cold IP buffer (150mM NaCl, 50mM Tris-HCl (pH 7.5), 5mM EDTA. 0.5% NP40 and 1% Triton X-100) and eluted with 1% SDS, 100mM NaHCO 3 , 10mM DTT at 65°C for 5min and RT for 15min. Crosslinking was reversed by incubation at 65°C overnight following the addition of NaCl to 150mM. The samples were treated with 100 µg/ml RNase (Roche) for 30 min at 37 °C and DNA was purified using a Qiagen PCR cleanup kit. Antibodies against H3K4me3 (clone 07-473 or MC315) and H3K27me3 (clone 07-449) were from Millipore, and Menin (AB2605) from Abcam.
Gel filtration. The procedures for gel filtration and associated data were as described in ref (32) .
Results

Down-regulation of p18 INK4c in replicative and oncogene-induced
senescence. When primary human diploid fibroblasts (HDFs) reach the end of their proliferative lifespan in culture, there is a substantial accumulation of p16 INK4a , preceded by a peak in p21 CIP1 expression which subsequently declines (25) . However, to our knowledge, there have been no reports on the expression of p18 INK4c in this classical model of senescence. We found that whereas p18 INK4c levels remained relatively constant with cumulative population doublings, they declined dramatically when the cells became senescent, essentially the mirror image of p16 INK4a expression levels ( Fig. 1A ).
This pattern of expression was recapitulated in different HDFs irrespective of their maximum lifespan and basal levels of p16 INK4a and p18 INK4c (data not shown).
As replicative senescence reflects both telomere-dependent and independent events, we asked whether a similar phenomenon occurs during Fig. S1 ) and (5, 28, 33, 34) . Second, the downregulation of p18 INK4c was not reversed by treatment with the proteasome inhibitor MG132 ( Fig. 1E ). Third, extinction of p18 INK4a at senescence was observed in the Leiden strain of human fibroblasts (24) , which lack functional p16 INK4a ( Fig. 1F ). substantially increased under the same conditions. Unlike other members of the INK4 family, the INK4c gene specifies two distinct transcripts that originate from alternative promoters but encode the same protein (35) . Using primers that discriminate between the two transcripts, we confirmed that both are down-regulated by RAS (Suppl. Fig. S2 ).
Down-regulation of p18
HDFs arrested by over-expression of p16 INK4a or other members of INK4 and CIP/KIP families acquire many features of senescence although they do not display the senescence-associated secretory phenotype associated with chronic DNA damage (36, 37) . We therefore investigated the fate of p18 INK4c in these circumstances. Interestingly, ectopic expression of on April 9, 2017. © 2011 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on November 11, 2011; DOI: 10.1158/0008-5472.CAN-11-2552 p21 CIP1 , p16 INK4a or p18 INK4c itself resulted in down-regulation of the endogenous INK4c gene ( Fig. 2E ).
These findings suggest that transcriptional silencing of INK4c is a consistent feature of senescent cells but make it unlikely that the loss of p18 INK4c has a causal role in the phenotype. In line with these reports, we found that in human fibroblasts undergoing H- 
Regulation of p18
RAS
Regulation of p18 INK4c by E2F.
As it seemed unlikely that the changes in menin levels could account for the dramatic down-regulation of INK4c, we considered the possibility that as an E2F-regulated gene (21, 39, 40) , INK4c was simply reacting to cell cycle arrest. However, agents that cause acute arrest in different cell cycle phases had no effect on the levels of Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on November 11, 2011; DOI: 10.1158/0008-5472. CAN-11-2552 previously used to demonstrate the inverse correlation between pRb status and p16 INK4a expression (28) . There was no consistent relationship between p16 INK4a and p18 INK4c expression or between p18 INK4c and pRb status ( Fig 4B) , in line with an earlier report (41) .
Taken together, our data imply that p18 INK4c expression is largely unaffected by the fluctuations of E2F activity that occur during the cell cycle or as a consequence of pRb inactivation. However, it was quite clearly induced by over-expression of E2F1, as confirmed using HDFs expressing a tamoxifen-regulated ER-E2F1 fusion protein (Suppl. Fig. S4C and S4D ). We therefore asked whether the down-regulation of INK4c at senescence correlated with reduced expression of E2F1. As shown in Figure 4C -F, the levels of E2F1 RNA and protein are consistently and dramatically reduced in fibroblasts undergoing either replicative, oncogene-or p16-induced senescence.
Distinction between activation and delayed repression of INK4c. It
was previously reported that shRNA-mediated knockdown of p16 INK4a in normal astrocytes caused an increase in the levels of p18 INK4c (21) . As this appeared to be at odds with our findings, we performed analogous experiments in human fibroblasts. In general, we found that shRNA-mediated knockdown of p16 INK4a had no discernible impact on the levels of p18 INK4c despite robust depletion of p16 INK4a (Fig. 5A ). This negative result was confirmed in multiple experiments with several different strains of logarithmically dividing cells (not shown). However, we occasionally noted higher levels of p18 INK4c in p16 INK4a -knockdown cells that had been in culture for some time. We reasoned that agents that suppress or disable the pRb- Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on November 11, 2011; DOI: 10.1158/0008-5472. CAN-11-2552 infected with the empty vector ( Fig. 5B ). It also reduced the basal levels of p16 INK4a but did not prevent the eventual accumulation of p16 INK4a at senescence ( Fig. 5C ). Importantly, the p18 INK4c levels declined much later in the Bmi1-transduced cells than in the controls. To illustrate this point more clearly, Figure 5D shows a direct comparison of cell lysates prepared on days 50 and 64 post-infection. At these time points, cells expressing Bmi1 appear to have substantially more p18 INK4a than the control, giving the false impression that p18 INK4c is being activated by Bmi1. Similar effects were observed in cells whose lifespan was extended by over-expression of CDK4 or p16-shRNA (data not shown). INK4c . One of the characteristic features of senescent fibroblasts is the appearance of senescence-associated heterochromatin foci (SAHF) which cause irreversible silencing of a subset of E2F target genes (42) . We wondered whether the silencing of INK4c at senescence was related to the formation of SAHFs. To avoid altering the levels of key components, we treated HDFs with the CDK4/6 inhibitor PD-0332991, which causes a pRb-dependent G1 arrest (43) and was recently shown to induce senescence in GBM cells that have codeletion of INK4a and INK4c (22, 23) . The stable arrest caused by PD-0332991 was accompanied by a decline in the expression of p18 INK4c RNA, as well as other E2F target genes (Fig. 6A) . Importantly, the cells developed characteristic features of senescence, and stained positively for SA-βgalactosidase and SAHFs ( Fig. 6B ). Of note, the loss of p18 INK4c expression was accompanied by down-regulation of both menin and E2F1 (Fig. 6C ).
Senescence-dependent and -independent effects on p18
However, for technical reasons, we were unable to draw a direct correlation between the appearance of SAHFs and elimination of p18 INK4c at the single cell level.
Reversing the logic, we asked whether H-RAS G12V would cause down- Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on November 11, 2011; DOI: 10.1158/0008-5472. CAN-11-2552 cells, although the effects were less dramatic than in the control fibroblasts ( Fig. 6D and 6E) . As H-RAS G12V caused down-regulation of p18 INK4c in MEFs ( Fig. 1D) where SAHFs are not observed (44) , our data suggest that SAHFs are not required for the down-regulation of INK4c by H-RAS G12V . Importantly, the correlation between p18 INK4c , E2F1 and menin expression still applied in Leiden cells despite the avoidance of senescence (Fig. 6F) . Taken together, our data suggest that there could be two distinct pathways leading to downregulation of INK4c, one instigated by CDK inhibition and the other instigated by RAS that appears to be independent of CDK inhibition. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Consequences of p18
Author Manuscript Published OnlineFirst on November 11, 2011; DOI: 10.1158/0008-5472.CAN- (Supp. Fig. S5A ). In proliferating cells, CDK6 is primarily associated with p18 INK4c as judged by co-immunoprecipitation, but in senescent cells, virtually all of the CDK6 becomes bound to p16 INK4a (Fig. 7D and Suppl. Fig. S5B ).
Although CDK4 can be found associated with p16 INK4a and p18 INK4c in early passage cells, its association with cyclin D1 is preserved at senescence despite the excess of p16 INK4a (Fig 7D and (32) ). In summary, the downregulation of p18 INK4c at senescence results in re-assortment of the D-cyclins, CDKs and CDK inhibitors to retain CDK6 in an apparently inactive state.
Discussion
A motivation for this study was the evidence that p18 INK4c acts as a tumor suppressor not only in mouse models but also in a number of human cancers.
Remarkably, deletions of INK4c have been found in tumors that also have defects in INK4a (17, (21) (22) (23) 45) prompting questions about the selective rationale for concomitant inactivation of two members of the same family. As mutation or silencing of p16 INK4a can enable incipient cancer cells to escape from oncogene-induced senescence, it was suggested that p18 INK4c serves as a backup in these circumstances, causing pressure to escape from p18 INK4cmediated arrest (21, 23) . The data we describe make this scenario unlikely.
In primary human fibroblasts undergoing senescence, whether in response to an activated oncogene, continuous passaging or CDK inhibitors, there is a marked decline in the expression of p18 INK4c which is effectively a mirror image of the dramatic accumulation of p16 INK4a in most of these settings. The down-regulation of INK4c occurs at the RNA level and has been previously documented in gene expression profiles of RAS-induced senescence (46) (47) (48) , although these studies did not discuss the implications.
We find that the effects on p18 INK4c are not dependent on the p16 INK4a status of the cell or on cell cycle arrest per se.
In seeking potential mechanisms, we considered known activators of A more cogent case can be made for E2F1. In situations where we observed loss of p18 INK4c expression, we invariably saw a substantial decline in the total levels of E2F1. Again, our findings agree with published evidence that E2F1 is down-regulated in replicative and H-RAS G12V -induced senescence (46, 49) . However, the interpretation is complicated by the fact that agents that modulate E2F1 activity rather than its total levels, such as cell Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on November 11, 2011; DOI: 10.1158/0008-5472. CAN-11-2552 Lysates from proliferating (P) and senescent (S) fibroblasts were immunoprecipitated with rabbit antibodies against CDK6, CDK4, p18 INK4c and p16 INK4a . The proteins were fractionated by SDS-PAGE and immunoblotted with mouse monoclonal antibodies against the indicated proteins. 
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